GTx, Inc. (NASDAQ:GTXI)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Recs

0
Player Avatar Popnfresh100 (85.26) Submitted: 11/2/2009 12:46:40 PM : Outperform Start Price: $4.88 GTXI Score: -64.72

Glimmers of hope- meeting with the FDA to discuss future rulings, drug has technically not been rejected.

Featured Broker Partners


Advertisement